SureTrader Advertisement Advertisement Advertisement
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

This a repost of mine from yahoo site

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
vorlon1966 Member Profile
Followed By 28
Posts 654
Boards Moderated 0
Alias Born 12/05/13
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/2/2015 5:06:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/29/2015 6:06:29 AM
Provectus Biopharmaceuticals Reports Publication of Review Paper on PV-10 Tumor Ablation and Immune Stimulation "Business Wire" - 9/29/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/23/2015 9:10:41 AM
Provectus Biopharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial to Study PV-10 in Combination with Immune Chec... "Business Wire" - 9/23/2015 8:49:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/21/2015 6:04:36 AM
Provectus Biopharmaceuticals Completes Patient Accrual for PH-10 Phase 2 Clinical Study of Cellular & Immunologic Changes in ... "Business Wire" - 9/21/2015 6:00:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 9/1/2015 5:02:40 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 8/21/2015 4:34:09 PM
Provectus Biopharmaceuticals Awarded US Patent Protecting Use of PV-10 as Part of Combination Therapy for Cancer "Business Wire" - 8/18/2015 9:25:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/18/2015 9:17:04 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/6/2015 6:37:36 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/6/2015 6:12:19 AM
Provectus Biopharmaceuticals Reports Second Quarter 2015 Financial Results "Business Wire" - 8/6/2015 6:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/28/2015 6:01:39 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/22/2015 6:05:39 AM
Provectus Biopharmaceuticals Will Hold Its 2015 Second Quarter Bus. Update Conference Call on Thursday, August 6, 2015, at 4 ... "Business Wire" - 7/22/2015 6:00:00 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 7/16/2015 5:04:19 PM
Provectus Biopharmaceuticals, Sinopharm-China State Institute of Pharmaceutical Industry & Sinopharm A-Think Pharmaceutical C... "Business Wire" - 7/15/2015 5:33:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/15/2015 5:18:57 PM
Provectus Biopharmaceuticals’ Phase 1 PV-10 Data on Liver Cancer Presented at 6th Asia-Pacific Primary Liver Cancer Expert ... "Business Wire" - 7/6/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/6/2015 7:41:59 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/2/2015 6:32:53 AM
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim (China) to Collaborate in Bringing PV-10 to Mar... "Business Wire" - 7/2/2015 6:30:00 AM
Provectus Biopharmaceuticals’ Data on PV-10 for Chemoablation of Liver Cancers Presented at ESMO 17th World Congress on Gas... "Business Wire" - 7/2/2015 6:00:00 AM
vorlon1966   Saturday, 12/28/13 12:08:00 PM
Re: buccaneer1961 post# 919
Post # of 7871 
This a repost of mine from yahoo site answering questions and comments.

They never failed
They shut down photogen to start pvct when they figured out they had a better product
They did get paid a few years a bunch.... They also are getting a product to market for around $130mm instead of $1.5 billion and in less time than normal.... We benefited from that because there are no partners to share in the end game... Probably would not be an end game otherwise....they would have taken over and you might have gotten a few bucks increase instead of the big payoff that's coming
They did not go for pIII right away when they realized they could invent a new synthesis for rb that can be approved internationally for oncology....99% purity
Patent awarded this year have to go into pIII with the drug that gets they waited for the patent
PIII? No mention in 8k..... What was mentioned was btd and aa
Deliberate omission? Judge for yourself.
Large production runs done for Nda and ready to ship...hmmmmm.
Second Pfizer guy on advisory board with Chinese pharma experience
They have been working on a Chinese regional deal waiting on FDA clarity....hmmmmm
First Pfizer board member is an acquisition specialist.....hmmmmm
They changed their name and state of incorporation......around same time as FDA meeting.....hmmmmm
Pfizer losing patents on Lipitor and Viagra .....hmmmmm

You guys not getting this......???? hmmmmmm...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist